Clinical Trial Update: Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer

View source ↗

Summary

A clinical trial update examining whether thymidylate synthase polymorphisms predict toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Colon Cancer | Status: UNKNOWN